1/296
Looks like no tags are added yet.
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
An antiretroviral therapy (ART) classification including Tenofovir and Zidovudine; side effects include headaches, weakness, N/V/D, liver & renal failure, lactic acidosis, rash, bone pain, lipodystrophy, seizure, and anxiety.
Tenofovir (Viread)
A Nucleoside Reverse Transcriptase Inhibitor (NRTI) administered orally once daily (PO daily).
Zidovudine (Retrovir)
A Nucleoside Reverse Transcriptase Inhibitor (NRTI) administered orally twice daily (PO BID).
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
An ART drug classification associated with dizziness, fatigue, drowsiness, headaches, impaired concentration, insomnia, liver failure, N/V/D, rash, high cholesterol, and lipodystrophy; will develop resistance quickly if non-compliant with medication.
Nevirapine (Viramune)
A Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) administered orally twice daily (PO BID).
Efarvirenz (Sustiva)
A Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) administered orally once daily (PO daily).
Protease Inhibitors
An ART drug classification whose side effects include seizures, abnormal thoughts, weakness, dizziness, headache, pharyngitis, angioedema, heart block, orthostatic hypotension, N/V/D, constipation, renal insufficiency, rashes, sweating, hyperglycemia, hyperlipidemia, lipodystrophy, and paresthesia.
Ritonavir (Norvir)
A Protease Inhibitor antiretroviral medication administered orally twice daily (PO BID).
Fusion Inhibitors
An ART drug classification associated with side effects including injection site reactions, pneumonia, nerve joint muscle pain, insomnia, and depression.
Enfuvirtide (Fuzeon)
A Fusion Inhibitor antiretroviral medication administered subcutaneously twice daily (SQ BID).
Chemokine Coreceptor Antagonists (CCR5 antagonist)
An ART drug classification whose side effects include N/V/D, constipation, fatigue, dizziness, insomnia, cough, runny nose, rash, muscle joint pain, and liver failure.
Maraviroc (Selzentry)
A Chemokine Coreceptor Antagonist (CCR5 antagonist) administered orally twice daily (PO BID).
Integrase Inhibitors
An ART drug classification represented by Raltegravir (Isentress) taken PO BID; side effects include suicide, headache, depression, fatigue, dizziness, insomnia, MI, N/V/D, liver failure, gastritis, renal failure, anemia, rash, and lipodystrophy.
Bictegravir + Tenofovir Alafenamide + Emtricitabine (Biktarvy)
A combination antiretroviral medication administered orally once daily (PO daily); diarrhea, nausea, and headache are the most common side effects, alongside serious side effects listed in constituent classifications.
Human Immunodeficiency Virus (HIV)
A chronic illness caused by a viral infection that targets and destroys CD4+ receptors on helper T cells, severely impairing adaptive cell-mediated immunity; it cannot be cured, but can be treated and controlled.
Acquired Immune Deficiency Syndrome (AIDS)
The end-stage condition resulting from untreated HIV, characterized by a non-functioning immune system and diagnosed when the CD4+ cell count falls below 200cells/microliter or when opportunistic infections manifest.
Acute HIV Infection
The initial stage of HIV infection occurring within weeks to months following exposure, characterized by rapid viral replication, destruction of CD4+ cells, and common flu-like manifestations such as fever, fatigue, lymphadenopathy, and joint or muscle aches.
Asymptomatic Chronic HIV Infection
A clinically latent stage occurring after acute infection where the immune system regains partial control over viral replication but cannot eliminate the virus, during which the patient often feels fine.
Symptomatic Chronic HIV Infection
The phase that ensues when control over viral replication is lost and the patient becomes moderately immunocompromised, presenting with minor infections like oral thrush and oral hairy leukoplakia, or unexplained symptoms such as persistent fever, severe weight loss, ulcerative stomatitis, or diarrhea lasting greater than 1month.
Highly Active Antiretroviral Therapy (HAART)
The recommended pharmacological treatment standard for HIV consisting of at least three different drugs from two different classes to interfere with viral reproduction and prevent the development of drug resistance.
Rapid Test (HIV)
A screening method using blood or oral fluids to detect the presence or absence of HIV antibodies; if negative, re-testing is recommended in 3 to 6months, and if positive, results must be confirmed with an HIV antibody assay.
ELISA (enzyme-linked immunosorbent assay)
A diagnostic screening test performed on blood, urine, or oral fluids to detect HIV antibodies; negative tests require follow-up in 3 to 6months, and positive results require confirmation via a Western blot test.
Western blot test
A confirmatory diagnostic assay used following a positive ELISA to identify specific viral protein bands associated with HIV.
PCR (polymerase chain reaction) test
A laboratory diagnostic test used to detect and quantify the HIV viral load present in a patient's plasma.
Nucleoside Reverse Transcriptase Inhibitors (NRTI)
A classification of antiretroviral drugs, including Tenofovir (Viread) and Zidovudine (Retrovir), with potential side effects that include lactic acidosis, bone pain, lipodystrophy, liver failure, and renal failure.
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)
A medication class including Nevirapine (Viramune) and Efarvirenz (Sustiva) that can cause dizziness, impaired concentration, rash, and liver failure, and will develop drug resistance quickly if the patient is non-compliant.
Protease Inhibitors
An antiretroviral drug class represented by Ritonavir (Norvir) whose adverse effects include hyperglycemia, hyperlipidemia, lipodystrophy, heart block, orthostatic hypotension, seizures, and renal insufficiency.
Enfuvirtide (Fuzeon)
A fusion inhibitor administered subcutaneously twice daily (SQ BID) with side effects that include injection site reactions, pneumonia, nerve, joint, or muscle pain, insomnia, and depression.
Immune Reconstruction Inflammatory Syndrome (IRIS)
A complication of HIV management characterized by an increased CD4+ cell count that triggers an exaggerated inflammatory response to existing or reemerging opportunistic infections.
STI vs STD
STI stands for Sexually Transmitted Infection, while STD stands for Sexually Transmitted Disease (previously termed venereal disease or VD), differing in whether the active infectious invasion has progressed to clinical disease and tissue pathology.
Florida Statute 384.24
A Florida legal statute that prohibits specific conduct involving designated sexually transmitted infections, with criminal penalties that vary based on individual circumstances.
Reportable STIs in Florida
The five sexually transmitted infections legally required to be reported to health authorities in Florida: HIV, Syphilis, Gonorrhea, Chlamydia, and Chancroid.
Major STI Risk Factors
High-risk circumstances and behaviors for acquiring STIs, including having new or multiple sexual partners, age between 15 and 24years, men who have sex with men (MSM), inconsistent condom or barrier use, sexual assault, intimate partner violence, and human trafficking or sexual exploitation.
Chlamydia and Gonorrhea Screening Guidelines
Clinical guidelines recommending annual screening for all sexually active women under 25years of age, while screening for women aged 25 and older or men is based on specific clinical risk factors and sexual practices.
Human Papillomavirus (HPV)
One of the most common viral STIs with over 200 identified genotypes; infections are frequently asymptomatic, often clear spontaneously, and can be prevented with targeted vaccination.
Low-Risk HPV
Non-oncogenic HPV strains, predominantly types 6 and 11, which are responsible for the vast majority of benign genital warts.
High-Risk HPV
Oncogenic HPV genotypes, most notably types 16 and 18, whose persistent infection significantly elevates the risk for cervical, anal, penile, vulvar, vaginal, and oropharyngeal cancers.

Condylomata Acuminata
Genital warts caused by low-risk HPV types (6 and 11), presenting as single or multiple, soft, flesh-colored or pink, typically painless verrucous lesions in genital or anal areas.
Pap Smear vs HPV Test
A Pap smear cytologically screens cervical cells for precancerous and cancerous dysplastic alterations, whereas an HPV molecular test directly detects the presence of high-risk oncogenic viral genotypes.

Colposcopy
A diagnostic procedure utilizing an illuminated magnifying instrument (colposcope) to directly visualize the cervix, vagina, or vulva and guide targeted tissue biopsies following abnormal cervical cancer screening results.

Imiquimod 5% Cream
A patient-applied topical medication prescribed for external genital warts that must be washed off after 6–10hours, causes local redness or burning, and requires abstaining from sexual contact while applied to the skin.

Treponema pallidum
The spirochete bacterium responsible for causing syphilis, transmitted via direct contact with infectious lesions during sexual activity or vertically across the placenta to a fetus.
Primary Syphilis
The initial stage of syphilis defined by the appearance of a single or multiple painless chancres at the site of bacterial entry, which typically heal spontaneously within 3–6weeks.
Secondary Syphilis
The systemic stage of syphilis appearing weeks to months after the primary chancre resolves, characterized by a generalized rash (frequently involving the palms and soles), mucous patches, fever, fatigue, and generalized lymphadenopathy.
Latent Syphilis
The quiescent, asymptomatic stage of syphilis during which clinical manifestations disappear, but the underlying Treponema pallidum infection remains active and detectable serologically.
Tertiary Syphilis
The destructive late stage of untreated syphilis that can emerge years after initial infection, leading to severe cardiovascular abnormalities, destructive gummatous lesions, and multi-organ damage.
Syphilis Treatment: Primary, Secondary, and Early Latent
A single intramuscular injection of Benzathine penicillin G at a dose of 2.4million units.
Syphilis Treatment: Late Latent or Unknown Duration
Intramuscular Benzathine penicillin G administered at 2.4million units once weekly for 3 consecutive weeks.
Jarisch–Herxheimer Reaction
A self-limiting, systemic inflammatory response featuring fever, chills, and headache occurring within the first 24hours of antibiotic therapy for syphilis caused by rapid spirochete lysis; it represents an expected reaction rather than a penicillin allergy.
Neurosyphilis
Central nervous system invasion by Treponema pallidum resulting in headache, cognitive deficits, altered mental status, and motor weakness, treated with intravenous aqueous crystalline penicillin G for 10–14days.
Ocular and Otosyphilis
Sensory organ complications of syphilis presenting with vision loss, hearing impairment, tinnitus, and vertigo, requiring urgent diagnostic evaluation and treatment equivalent to neurosyphilis.

Congenital Syphilis
Transplacental transmission of Treponema pallidum from mother to fetus, which can lead to miscarriage, stillbirth, neonatal infection, and manifestations such as maculopapular rash, bullous lesions, desquamation, mucous patches, and rhagades.
Herpes Simplex Virus (HSV-1 and HSV-2)
Viral pathogens that infect via direct mucosal or skin-to-skin contact (even during asymptomatic viral shedding), causing genital herpes characterized by painful fluid-filled vesicles that rupture into shallow ulcers.
Primary Genital Herpes Outbreak
The initial, often most severe clinical manifestation of genital herpes, featuring painful vesicles and ulcers accompanied by systemic symptoms such as fever, myalgias, dysuria, and tender inguinal lymphadenopathy.
Suppressive Therapy for HSV
Continuous, daily oral antiviral therapy (using acyclovir, valacyclovir, or famciclovir) to decrease the frequency of recurrent genital herpes outbreaks and reduce HSV-2 transmission to susceptible partners.
Aseptic Meningitis in HSV
An uncommon viral neurologic complication of herpes simplex infection, occurring most frequently in association with primary HSV-2 genital outbreaks.

Herpetic Keratitis
A serious ocular complication of herpes simplex virus infection affecting the cornea, characteristically causing branching dendritic ulcerations and potential vision impairment.
Neonatal Herpes
Transmission of HSV to an infant primarily during passage through an infected birth canal, potentially causing localized skin, eye, and mouth (SEM) disease, central nervous system involvement, or fatal disseminated infection.
Chlamydia trachomatis
A prevalent bacterial pathogen responsible for chlamydia; it is frequently asymptomatic ('the dirty little secret') but can cause severe reproductive tract scarring and tubal injury if left untreated.
Clinical Manifestations of Chlamydia
Presentations in females include altered vaginal discharge, intermenstrual bleeding, lower abdominal pain, and dysuria; in males, symptoms include burning with urination, penile discharge, and testicular pain or swelling.
Chlamydia Treatment Regimens
Nonpregnant adults are treated with oral doxycycline 100mg twice daily for 7days, whereas pregnant patients are treated with a single oral dose of azithromycin 1g.
Partner Notification and Retesting for Chlamydia
The clinical standard requiring presumptive evaluation and treatment of all sexual partners from the preceding 60days, complete sexual abstinence until 7days of treatment are finished, and mandatory retesting approximately 3months post-treatment.
Reactive Arthritis
A systemic autoimmune inflammatory joint complication (formerly known as Reiter syndrome) that can develop as a sequela of untreated Chlamydia trachomatis infection.
Neisseria gonorrhoeae
A Gram-negative bacterial diplococcus causing gonorrhea (colloquially called 'the clap'), which infects mucous membranes of the cervix, urethra, rectum, and pharynx and presents significant challenges due to rising antimicrobial resistance.

First-Line Treatment for Uncomplicated Gonorrhea
A single intramuscular injection of ceftriaxone 500mg (1g for patients weighing ≥150kg), supplemented with oral doxycycline 100mg twice daily for 7days if chlamydial coinfection has not been ruled out.
Disseminated Gonococcal Infection (DGI)
Systemic hematogenous dissemination of Neisseria gonorrhoeae from the initial mucosal site into the bloodstream, manifesting clinically as migratory polyarthralgia, tenosynovitis, skin lesions, or purulent septic arthritis.
Neonatal Gonococcal Ophthalmia
A virulent form of conjunctivitis acquired by an infant during delivery from an untreated mother, which can lead to rapid corneal ulceration, perforation, and permanent blindness if not promptly treated.

Trichomonas vaginalis
A flagellated protozoan parasite that infects the lower urogenital tract, causing trichomoniasis, with approximately 70%–85% of infected individuals exhibiting minimal or no clinical symptoms.

Strawberry Cervix (Colpitis Macularis)
A classic, visually distinctive cervical sign associated with trichomoniasis, characterized by diffuse punctate petechial mucosal hemorrhages across the exocervix.
Bacterial Vaginosis (BV)
A non-STI vaginal microbial imbalance caused by a reduction in protective Lactobacillus species and an overgrowth of anaerobic bacteria, typically presenting with a thin, homogeneous gray-white discharge and an amine 'fishy' odor.
Pelvic Inflammatory Disease (PID)
An ascending polymicrobial infection of the female upper reproductive tract (uterus, fallopian tubes, and ovaries)—commonly resulting from untreated gonorrhea or chlamydia—that causes pelvic pain, cervical motion tenderness, ectopic pregnancy, and tubal factor infertility.
External Ear
The outermost division of the ear that collects sound, consisting of the pinna (auricle), external ear canal, and tympanic membrane.
Middle Ear
An air-filled cavity that transmits vibrations across the ossicles (malleus, incus, and stapes) and connects to the nasopharynx via the Eustachian tube.
Inner Ear
The sensory organ responsible for hearing and balance, comprising the fluid-filled cochlea, vestibule, and semicircular canals.
Normal Tympanic Membrane
A healthy, translucent eardrum displaying distinct anatomical landmarks including the pars flaccida, pars tensa, handle and lateral process of the malleus, and a crisp cone of light (light reflex).

Bulging Tympanic Membrane
An abnormal eardrum finding characterized by erythema, loss of visible landmarks, and outward distension toward the canal, typically caused by purulent middle ear effusion.

Age-Related Auditory Changes
Normal physiological changes with aging that include drier and harder cerumen, coarser ear canal hair, decreased tympanic membrane flexibility, degeneration of cochlear hair cells, and high-frequency hearing decline.
Conductive Hearing Loss
Hearing impairment caused by physical obstruction or mechanical dysfunction in the outer or middle ear (such as cerumen impaction, otitis media, or otosclerosis) that disrupts sound transmission; often treatable.
Sensorineural Hearing Loss
Hearing impairment caused by damage to the inner ear structures or the auditory nerve pathways (such as from aging, intense noise exposure, or ototoxic drugs) that interferes with sound detection; often permanent.
Weber Test
A tuning fork test placed at the midline of the skull where sound localizes to the affected ear in conductive hearing loss and to the better ear in sensorineural hearing loss ("tells you WHERE").
Rinne Test
A tuning fork test comparing air conduction (AC) to bone conduction (BC); normal is AC>BC, conductive loss is BC≥AC, and sensorineural loss is AC>BC with reduced overall hearing ("tells you HOW").
Audiometry
A formal diagnostic hearing evaluation that quantifies hearing thresholds to identify the specific type and degree of hearing loss to guide treatment ("tells you HOW MUCH").
Cochlear Implants
Surgically implanted electronic devices that bypass damaged hair cells to stimulate the auditory nerve directly in selected patients with significant sensorineural hearing loss.
Tinnitus
The perception of auditory noise (such as ringing, buzzing, hissing, or roaring) without an external acoustic source, commonly linked to hearing loss, noise trauma, or ototoxicity.
Ototoxic Medications
Pharmacologic agents known to induce cochlear or vestibular toxicity, including aminoglycosides (gentamicin, tobramycin), loop diuretics (furosemide), platinum chemotherapy (cisplatin), high-dose salicylates (aspirin), and vancomycin.
Vertigo
An illusionary sensation of rotational movement or spinning when stationary, typically resulting from inner ear vestibular dysfunction and distinct from lightheadedness or faintness.
Benign Paroxysmal Positional Vertigo (BPPV)
The most common form of peripheral vertigo, marked by brief spinning episodes typically lasting less than 1 minute provoked by specific head position changes without causing hearing loss or tinnitus.
Otoconia
Microscopic calcium carbonate crystals that originate in the utricle and saccule; when displaced into a semicircular canal, head movement causes them to trigger false vestibular signals of motion.
Dix-Hallpike Test
A clinical diagnostic positional maneuver used to provoke nystagmus and vertigo to confirm the diagnosis of BPPV.
Epley Maneuver
A series of sequential head and body repositioning movements used to migrate displaced otoconia out of the semicircular canal back into the vestibule.
Meclizine
An oral antihistaminic vestibular suppressant prescribed for short-term symptom relief of acute vertigo and associated nausea.
Ménière's Disease
An inner ear condition driven by excess endolymphatic fluid accumulation, presenting with episodic vertigo (20 minutes to 12 hours), fluctuating sensorineural hearing loss, tinnitus, and aural fullness.
Sodium Restriction in Ménière's Disease
An individualized non-pharmacological dietary intervention aimed at reducing endolymphatic fluid retention and moderating inner ear fluid pressures.
Otitis Externa
Infection and inflammation of the external auditory canal (commonly known as swimmer's ear), presenting with canal erythema, swelling, purulent drainage, and severe pain with pinna traction or tragus pressure.
Tragus Sign
Severe discomfort elicited upon direct pressure over the tragus or pulling of the pinna; a hallmark clinical indicator distinguishing otitis externa from otitis media.
Impacted Cerumen
Occlusion of the external ear canal by dense, hardened wax, leading to conductive hearing loss, a sensation of fullness, tinnitus, and occasional reflex coughing.
Ear Irrigation Technique
A cleansing procedure using body-temperature solution directed gently along the upper or posterior canal wall with the adult pinna retracted upward and backward; strictly avoided if tympanic membrane integrity is uncertain or perforated.
Serous Otitis Media
The presence of non-infectious fluid behind an intact tympanic membrane, often following an upper respiratory infection or Eustachian tube dysfunction, presenting with a dull eardrum and visible air bubbles or air-fluid levels.

Acute Otitis Media (AOM)
An acute bacterial or viral infection of the middle ear space causing otalgia, fever, systemic irritability, and a red, bulging eardrum with obscured bony landmarks.
Mastoiditis
A dangerous extension of an untreated or resolving middle ear infection into the mastoid air cells, characterized by high fever, postauricular erythema and swelling, severe tenderness, and an outwardly protruding auricle.
